A new trading day began on Tuesday, with Cogent Biosciences Inc (NASDAQ: COGT) stock price up 4.73% from the previous day of trading, before settling in for the closing price of $9.19. COGT’s price has ranged from $3.67 to $12.61 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -6.78% over the last five years. Meanwhile, its annual earnings per share averaged 0.00%. With a float of $88.93 million, this company’s outstanding shares have now reached $110.46 million.
The firm has a total of 164 workers. Let’s measure their productivity. In terms of profitability, gross margin is 47.39%, operating margin of -4660.58%, and the pretax margin is -4336.02%.
Cogent Biosciences Inc (COGT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cogent Biosciences Inc is 19.50%, while institutional ownership is 91.32%.
Cogent Biosciences Inc (COGT) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.63 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.00% per share during the next fiscal year.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Here are Cogent Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.48, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -2.31 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Analysing the last 5-days average volume posted by the [Cogent Biosciences Inc, COGT], we can find that recorded value of 1.06 million was lower than the volume posted last year of 1.42 million. As of the previous 9 days, the stock’s Stochastic %D was 33.78%. Additionally, its Average True Range was 0.62.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 30.90%, which indicates a significant decrease from 40.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.74% in the past 14 days, which was lower than the 55.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.78, while its 200-day Moving Average is $8.85. Now, the first resistance to watch is $9.86. This is followed by the second major resistance level at $10.10. The third major resistance level sits at $10.50. If the price goes on to break the first support level at $9.22, it is likely to go to the next support level at $8.82. Should the price break the second support level, the third support level stands at $8.58.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
With a market capitalization of 1.06 billion, the company has a total of 110,462K Shares Outstanding. Currently, annual sales are 0 K while annual income is -192,410 K. The company’s previous quarter sales were 0 K while its latest quarter income was -70,630 K.
